 | • レポートコード：GIR-2104Z11184 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ポリペプチド薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ポリペプチド薬の種類別市場規模（注射、経鼻投与、肺投与、経口投与、経皮投与）、用途別市場規模（免疫調節薬（アレルギー感染症・免疫）、消化器系薬（胃腸型）、骨・結合組織型（甲状腺ホルモン薬）、婦人科・産科薬、腫瘍薬、泌尿器系薬、代謝薬（インスリン・その他血糖降下薬））、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ポリペプチド薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Novartis、Merck Serono、Ferring Pharmaceuticals、Ipsen PHarma Biotech、Lilly、Asahi Kasei、AstraZeneca、SciClone Pharmaceuticals、Takeda、Roche、Sanofi ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：注射、経鼻投与、肺投与、経口投与、経皮投与 ・用途別分析2016年-2026年：免疫調節薬（アレルギー感染症・免疫）、消化器系薬（胃腸型）、骨・結合組織型（甲状腺ホルモン薬）、婦人科・産科薬、腫瘍薬、泌尿器系薬、代謝薬（インスリン・その他血糖降下薬） ・ポリペプチド薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ポリペプチド薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ポリペプチド薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ポリペプチド薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ポリペプチド薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Polypeptide Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Polypeptide Drug size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Polypeptide Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Polypeptide Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Injection
Nasal Administration
Lung Administration
Oral Administration
Transdermal Administration
Market segment by Application can be divided into
Immunity Regulating Medicine (Allergy Infection and Immune)
Digestive System Drugs (Gastrointestinal Type)
Bone and Connective Tissue Types (Thyroid hormones Drug)
Gynecologic or Obstetric Drug
Tumor Drug
Urinary System Drug
Metabolic Drug (Insulin and Other Hypoglycemic Agents)
The key market players for global Polypeptide Drug market are listed below:
Novartis
Merck Serono
Ferring Pharmaceuticals
Ipsen PHarma Biotech
Lilly
Asahi Kasei
AstraZeneca
SciClone Pharmaceuticals
Takeda
Roche
Sanofi
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Polypeptide Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Polypeptide Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Injection
1.2.3 Nasal Administration
1.2.4 Lung Administration
1.2.5 Oral Administration
1.2.6 Transdermal Administration
1.3 Market Analysis by Application
1.3.1 Overview: Global Polypeptide Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Immunity Regulating Medicine (Allergy Infection and Immune)
1.3.3 Digestive System Drugs (Gastrointestinal Type)
1.3.4 Bone and Connective Tissue Types (Thyroid hormones Drug)
1.3.5 Gynecologic or Obstetric Drug
1.3.6 Tumor Drug
1.3.7 Urinary System Drug
1.3.8 Metabolic Drug (Insulin and Other Hypoglycemic Agents)
1.4 Global Polypeptide Drug Market Size & Forecast
1.4.1 Global Polypeptide Drug Sales in Value (2016-2026))
1.4.2 Global Polypeptide Drug Sales in Volume (2016-2026)
1.4.3 Global Polypeptide Drug Price by Type (2016-2026) & (USD/MT)
1.5 Global Polypeptide Drug Production Capacity Analysis
1.5.1 Global Polypeptide Drug Total Production Capacity (2016-2026)
1.5.2 Global Polypeptide Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Polypeptide Drug Market Drivers
1.6.2 Polypeptide Drug Market Restraints
1.6.3 Polypeptide Drug Trends Analysis
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Polypeptide Drug Product and Services
2.1.4 Novartis Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Merck Serono
2.2.1 Merck Serono Details
2.2.2 Merck Serono Major Business
2.2.3 Merck Serono Polypeptide Drug Product and Services
2.2.4 Merck Serono Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Ferring Pharmaceuticals
2.3.1 Ferring Pharmaceuticals Details
2.3.2 Ferring Pharmaceuticals Major Business
2.3.3 Ferring Pharmaceuticals Polypeptide Drug Product and Services
2.3.4 Ferring Pharmaceuticals Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Ipsen PHarma Biotech
2.4.1 Ipsen PHarma Biotech Details
2.4.2 Ipsen PHarma Biotech Major Business
2.4.3 Ipsen PHarma Biotech Polypeptide Drug Product and Services
2.4.4 Ipsen PHarma Biotech Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Lilly
2.5.1 Lilly Details
2.5.2 Lilly Major Business
2.5.3 Lilly Polypeptide Drug Product and Services
2.5.4 Lilly Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Asahi Kasei
2.6.1 Asahi Kasei Details
2.6.2 Asahi Kasei Major Business
2.6.3 Asahi Kasei Polypeptide Drug Product and Services
2.6.4 Asahi Kasei Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 AstraZeneca
2.7.1 AstraZeneca Details
2.7.2 AstraZeneca Major Business
2.7.3 AstraZeneca Polypeptide Drug Product and Services
2.7.4 AstraZeneca Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 SciClone Pharmaceuticals
2.8.1 SciClone Pharmaceuticals Details
2.8.2 SciClone Pharmaceuticals Major Business
2.8.3 SciClone Pharmaceuticals Polypeptide Drug Product and Services
2.8.4 SciClone Pharmaceuticals Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Takeda
2.9.1 Takeda Details
2.9.2 Takeda Major Business
2.9.3 Takeda Polypeptide Drug Product and Services
2.9.4 Takeda Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Roche
2.10.1 Roche Details
2.10.2 Roche Major Business
2.10.3 Roche Polypeptide Drug Product and Services
2.10.4 Roche Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Sanofi
2.11.1 Sanofi Details
2.11.2 Sanofi Major Business
2.11.3 Sanofi Polypeptide Drug Product and Services
2.11.4 Sanofi Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Polypeptide Drug Sales by Manufacturer
3.1 Global Polypeptide Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Polypeptide Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Polypeptide Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Polypeptide Drug Manufacturer Market Share
3.4.2 Top 6 Polypeptide Drug Manufacturer Market Share
3.5 Global Polypeptide Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Polypeptide Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Polypeptide Drug Market Size by Region
4.1.1 Global Polypeptide Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Polypeptide Drug Revenue by Region (2016-2026)
4.2 North America Polypeptide Drug Revenue (2016-2026)
4.3 Europe Polypeptide Drug Revenue (2016-2026)
4.4 Asia-Pacific Polypeptide Drug Revenue (2016-2026)
4.5 South America Polypeptide Drug Revenue (2016-2026)
4.6 Middle East and Africa Polypeptide Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Polypeptide Drug Sales in Volume by Type (2016-2026)
5.2 Global Polypeptide Drug Revenue by Type (2016-2026)
5.3 Global Polypeptide Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Polypeptide Drug Sales in Volume by Application (2016-2026)
6.2 Global Polypeptide Drug Revenue by Application (2016-2026)
6.3 Global Polypeptide Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Polypeptide Drug Sales by Type (2016-2026)
7.2 North America Polypeptide Drug Sales by Application (2016-2026)
7.3 North America Polypeptide Drug Market Size by Country
7.3.1 North America Polypeptide Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Polypeptide Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Polypeptide Drug Sales by Type (2016-2026)
8.2 Europe Polypeptide Drug Sales by Application (2016-2026)
8.3 Europe Polypeptide Drug Market Size by Country
8.3.1 Europe Polypeptide Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Polypeptide Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Polypeptide Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Polypeptide Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Polypeptide Drug Market Size by Region
9.3.1 Asia-Pacific Polypeptide Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Polypeptide Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Polypeptide Drug Sales by Type (2016-2026)
10.2 South America Polypeptide Drug Sales by Application (2016-2026)
10.3 South America Polypeptide Drug Market Size by Country
10.3.1 South America Polypeptide Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Polypeptide Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Polypeptide Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Polypeptide Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Polypeptide Drug Market Size by Country
11.3.1 Middle East & Africa Polypeptide Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Polypeptide Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Polypeptide Drug Typical Distributors
12.3 Polypeptide Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Polypeptide Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Polypeptide Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Polypeptide Drug Product and Services
Table 6. Novartis Polypeptide Drug Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Merck Serono Basic Information, Manufacturing Base and Competitors
Table 8. Merck Serono Major Business
Table 9. Merck Serono Polypeptide Drug Product and Services
Table 10. Merck Serono Polypeptide Drug Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Ferring Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Ferring Pharmaceuticals Major Business
Table 13. Ferring Pharmaceuticals Polypeptide Drug Product and Services
Table 14. Ferring Pharmaceuticals Polypeptide Drug Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Ipsen PHarma Biotech Basic Information, Manufacturing Base and Competitors
Table 16. Ipsen PHarma Biotech Major Business
Table 17. Ipsen PHarma Biotech Polypeptide Drug Product and Services
Table 18. Ipsen PHarma Biotech Polypeptide Drug Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Lilly Basic Information, Manufacturing Base and Competitors
Table 20. Lilly Major Business
Table 21. Lilly Polypeptide Drug Product and Services
Table 22. Lilly Polypeptide Drug Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Asahi Kasei Basic Information, Manufacturing Base and Competitors
Table 24. Asahi Kasei Major Business
Table 25. Asahi Kasei Polypeptide Drug Product and Services
Table 26. Asahi Kasei Polypeptide Drug Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 28. AstraZeneca Major Business
Table 29. AstraZeneca Polypeptide Drug Product and Services
Table 30. AstraZeneca Polypeptide Drug Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. SciClone Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. SciClone Pharmaceuticals Major Business
Table 33. SciClone Pharmaceuticals Polypeptide Drug Product and Services
Table 34. SciClone Pharmaceuticals Polypeptide Drug Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Takeda Basic Information, Manufacturing Base and Competitors
Table 36. Takeda Major Business
Table 37. Takeda Polypeptide Drug Product and Services
Table 38. Takeda Polypeptide Drug Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Roche Basic Information, Manufacturing Base and Competitors
Table 40. Roche Major Business
Table 41. Roche Polypeptide Drug Product and Services
Table 42. Roche Polypeptide Drug Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Sanofi Basic Information, Manufacturing Base and Competitors
Table 44. Sanofi Major Business
Table 45. Sanofi Polypeptide Drug Product and Services
Table 46. Sanofi Polypeptide Drug Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Polypeptide Drug Sales by Manufacturer (2019-2021e) & (MT)
Table 48. Global Polypeptide Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Polypeptide Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Polypeptide Drug Production Capacity by Company, (MT): 2020 VS 2021
Table 51. Head Office and Polypeptide Drug Production Site of Key Manufacturer
Table 52. Global Polypeptide Drug Sales by Region (2016-2021e) & (MT)
Table 53. Global Polypeptide Drug Sales by Region (2021-2026) & (MT)
Table 54. Global Polypeptide Drug Revenue by Region (2016-2021e) & (USD Million)
Table 55. Global Polypeptide Drug Revenue by Region (2021-2026) & (USD Million)
Table 56. Global Polypeptide Drug Sales by Type (2016-2021e) & (MT)
Table 57. Global Polypeptide Drug Sales by Type (2021-2026) & (MT)
Table 58. Global Polypeptide Drug Revenue by Type (2016-2021e) & (USD Million)
Table 59. Global Polypeptide Drug Revenue by Type (2021-2026) & (USD Million)
Table 60. Global Polypeptide Drug Price by Type (2016-2021e) & (USD/MT)
Table 61. Global Polypeptide Drug Price by Type (2021-2026) & (USD/MT)
Table 62. Global Polypeptide Drug Sales by Application (2016-2021e) & (MT)
Table 63. Global Polypeptide Drug Sales by Application (2021-2026) & (MT)
Table 64. Global Polypeptide Drug Revenue by Application (2016-2021e) & (USD Million)
Table 65. Global Polypeptide Drug Revenue by Application (2021-2026) & (USD Million)
Table 66. Global Polypeptide Drug Price by Application (2016-2021e) & (USD/MT)
Table 67. Global Polypeptide Drug Price by Application (2021-2026) & (USD/MT)
Table 68. North America Polypeptide Drug Sales by Country (2016-2021e) & (MT)
Table 69. North America Polypeptide Drug Sales by Country (2021-2026) & (MT)
Table 70. North America Polypeptide Drug Revenue by Country (2016-2021e) & (USD Million)
Table 71. North America Polypeptide Drug Revenue by Country (2021-2026) & (USD Million)
Table 72. North America Polypeptide Drug Sales by Type (2016-2021e) & (MT)
Table 73. North America Polypeptide Drug Sales by Type (2021-2026) & (MT)
Table 74. North America Polypeptide Drug Sales by Application (2016-2021e) & (MT)
Table 75. North America Polypeptide Drug Sales by Application (2021-2026) & (MT)
Table 76. Europe Polypeptide Drug Sales by Country (2016-2021e) & (MT)
Table 77. Europe Polypeptide Drug Sales by Country (2021-2026) & (MT)
Table 78. Europe Polypeptide Drug Revenue by Country (2016-2021e) & (USD Million)
Table 79. Europe Polypeptide Drug Revenue by Country (2021-2026) & (USD Million)
Table 80. Europe Polypeptide Drug Sales by Type (2016-2021e) & (MT)
Table 81. Europe Polypeptide Drug Sales by Type (2021-2026) & (MT)
Table 82. Europe Polypeptide Drug Sales by Application (2016-2021e) & (MT)
Table 83. Europe Polypeptide Drug Sales by Application (2021-2026) & (MT)
Table 84. Asia-Pacific Polypeptide Drug Sales by Region (2016-2021e) & (MT)
Table 85. Asia-Pacific Polypeptide Drug Sales by Region (2021-2026) & (MT)
Table 86. Asia-Pacific Polypeptide Drug Revenue by Region (2016-2021e) & (USD Million)
Table 87. Asia-Pacific Polypeptide Drug Revenue by Region (2021-2026) & (USD Million)
Table 88. Asia-Pacific Polypeptide Drug Sales by Type (2016-2021e) & (MT)
Table 89. Asia-Pacific Polypeptide Drug Sales by Type (2021-2026) & (MT)
Table 90. Asia-Pacific Polypeptide Drug Sales by Application (2016-2021e) & (MT)
Table 91. Asia-Pacific Polypeptide Drug Sales by Application (2021-2026) & (MT)
Table 92. South America Polypeptide Drug Sales by Country (2016-2021e) & (MT)
Table 93. South America Polypeptide Drug Sales by Country (2021-2026) & (MT)
Table 94. South America Polypeptide Drug Revenue by Country (2016-2021e) & (USD Million)
Table 95. South America Polypeptide Drug Revenue by Country (2021-2026) & (USD Million)
Table 96. South America Polypeptide Drug Sales by Type (2016-2021e) & (MT)
Table 97. South America Polypeptide Drug Sales by Type (2021-2026) & (MT)
Table 98. South America Polypeptide Drug Sales by Application (2016-2021e) & (MT)
Table 99. South America Polypeptide Drug Sales by Application (2021-2026) & (MT)
Table 100. Middle East & Africa Polypeptide Drug Sales by Country (2016-2021e) & (MT)
Table 101. Middle East & Africa Polypeptide Drug Sales by Country (2021-2026) & (MT)
Table 102. Middle East & Africa Polypeptide Drug Revenue by Country (2016-2021e) & (USD Million)
Table 103. Middle East & Africa Polypeptide Drug Revenue by Country (2021-2026) & (USD Million)
Table 104. Middle East & Africa Polypeptide Drug Sales by Type (2016-2021e) & (MT)
Table 105. Middle East & Africa Polypeptide Drug Sales by Type (2021-2026) & (MT)
Table 106. Middle East & Africa Polypeptide Drug Sales by Application (2016-2021e) & (MT)
Table 107. Middle East & Africa Polypeptide Drug Sales by Application (2021-2026) & (MT)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Polypeptide Drug Typical Distributors
Table 111. Polypeptide Drug Typical Customers
List of Figures
Figure 1. Polypeptide Drug Picture
Figure 2. Global Polypeptide Drug Sales Market Share by Type in 2020
Figure 3. Injection
Figure 4. Nasal Administration
Figure 5. Lung Administration
Figure 6. Oral Administration
Figure 7. Transdermal Administration
Figure 8. Global Polypeptide Drug Sales Market Share by Application in 2020
Figure 9. Immunity Regulating Medicine (Allergy Infection and Immune)
Figure 10. Digestive System Drugs (Gastrointestinal Type)
Figure 11. Bone and Connective Tissue Types (Thyroid hormones Drug)
Figure 12. Gynecologic or Obstetric Drug
Figure 13. Tumor Drug
Figure 14. Urinary System Drug
Figure 15. Metabolic Drug (Insulin and Other Hypoglycemic Agents)
Figure 16. Global Polypeptide Drug Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 17. Global Polypeptide Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 18. United States Polypeptide Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Canada Polypeptide Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Mexico Polypeptide Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Germany Polypeptide Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. France Polypeptide Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. United Kingdom Polypeptide Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Russia Polypeptide Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Italy Polypeptide Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. China Polypeptide Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Japan Polypeptide Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Korea Polypeptide Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. India Polypeptide Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Southeast Asia Polypeptide Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Australia Polypeptide Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Brazil Polypeptide Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Egypt Polypeptide Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Saudi Arabia Polypeptide Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. South Africa Polypeptide Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 36. Turkey Polypeptide Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 37. Global Polypeptide Drug Sales (2016-2026) & (MT)
Figure 38. Global Polypeptide Drug Production Capacity (2016-2026) & (MT)
Figure 39. Global Polypeptide Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 40. Polypeptide Drug Market Drivers
Figure 41. Polypeptide Drug Market Restraints
Figure 42. Polypeptide Drug Market Trends
Figure 43. Global Polypeptide Drug Sales Market Share by Manufacturer in 2020
Figure 44. Global Polypeptide Drug Revenue Market Share by Manufacturer in 2020
Figure 45. Polypeptide Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 46. Top 3 Polypeptide Drug Manufacturer (Revenue) Market Share in 2020
Figure 47. Top 6 Polypeptide Drug Manufacturer (Revenue) Market Share in 2020
Figure 48. Global Polypeptide Drug Sales Market Share by Region (2016-2026)
Figure 49. Global Polypeptide Drug Revenue Market Share by Region (2016-2026)
Figure 50. North America Polypeptide Drug Revenue (2016-2026) & (USD Million)
Figure 51. Europe Polypeptide Drug Revenue (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Polypeptide Drug Revenue (2016-2026) & (USD Million)
Figure 53. South America Polypeptide Drug Revenue (2016-2026) & (USD Million)
Figure 54. Middle East & Africa Polypeptide Drug Revenue (2016-2026) & (USD Million)
Figure 55. Global Polypeptide Drug Sales Market Share by Type (2016-2026)
Figure 56. Global Polypeptide Drug Revenue Market Share by Type (2016-2026)
Figure 57. Global Polypeptide Drug Price by Type (2016-2026) & (USD/MT)
Figure 58. Global Polypeptide Drug Sales Market Share by Application (2016-2026)
Figure 59. Global Polypeptide Drug Revenue Market Share by Application (2016-2026)
Figure 60. Global Polypeptide Drug Price by Application (2016-2026) & (USD/MT)
Figure 61. North America Polypeptide Drug Sales Market Share by Country (2016-2026)
Figure 62. North America Polypeptide Drug Revenue Market Share by Country (2016-2026)
Figure 63. North America Polypeptide Drug Sales Market Share by Type (2016-2026)
Figure 64. North America Polypeptide Drug Sales Market Share by Application (2016-2026)
Figure 65. Europe Polypeptide Drug Sales Market Share by Country (2016-2026)
Figure 66. Europe Polypeptide Drug Revenue Market Share by Country (2016-2026)
Figure 67. Europe Polypeptide Drug Sales Market Share by Type (2016-2026)
Figure 68. Europe Polypeptide Drug Sales Market Share by Application (2016-2026)
Figure 69. Asia-Pacific Polypeptide Drug Sales Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Polypeptide Drug Revenue Market Share by Region (2016-2026)
Figure 71. Asia-Pacific Polypeptide Drug Sales Market Share by Region (2016-2026)
Figure 72. Asia-Pacific Polypeptide Drug Sales Market Share by Application (2016-2026)
Figure 73. South America Polypeptide Drug Sales Market Share by Country (2016-2026)
Figure 74. South America Polypeptide Drug Revenue Market Share by Country (2016-2026)
Figure 75. South America Polypeptide Drug Sales Market Share by Type (2016-2026)
Figure 76. South America Polypeptide Drug Sales Market Share by Application (2016-2026)
Figure 77. Middle East & Africa Polypeptide Drug Sales Market Share by Country (2016-2026)
Figure 78. Middle East & Africa Polypeptide Drug Revenue Market Share by Country (2016-2026)
Figure 79. Middle East & Africa Polypeptide Drug Sales Market Share by Type (2016-2026)
Figure 80. Middle East & Africa Polypeptide Drug Sales Market Share by Application (2016-2026)
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
世界のゼラチンポリペプチド血漿増量剤市場 2021：企業別、地域別、種類・用途別 The Gelatin Polypeptide Plasma Expander market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…- 世界のアレルギー性鼻炎治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Allergy Rhinitis Drug Market The global Allergy Rhinitis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report…
- 世界の経鼻ドラッグデリバリー市場規模・現状・予測（2021年-2027年） Nasal Drug Delivery is a route of administration in which drugs are insufflated through the nose. It can be a form of either topical administration or systemic administration, as the drugs thus locally delivered can go on to have either purely local or systemic effects. Nasal sprays are locally acti…
- 世界の薬物検査用口腔液市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drug Test Oral Fluid Market The global Drug Test Oral Fluid market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report m…
- 世界の薬物アレルギー治療・薬剤市場 2021：企業別、地域別、種類・用途別 The Drug Allergy Treatments and Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…